Compliance Rate

Compliance Rate 31.0%
Compliant submissions 31
Incompliant submissions 69
Total trials 100

Your Clinical Trials

Showing 100 of 100 entries
View as:

Randomized Trial of Beta-Carotene and Macular Degeneration

Phase: N/A Priority: Normal
NCT ID: NCT00000152 Org: User:
Start: 04/30/82 End: - Due: -

Naltrexone for Relapse Prevention

Phase: N/A Priority: Normal
NCT ID: NCT00000442 Org: User:
Start: - End: 12/31/02 Due: 12/31/03

Effects of Dextromethorphan on Opioid Tolerance in Methadone Patients - 1

Phase: N/A Priority: Normal
NCT ID: NCT00000352 Org: User:
Start: 12/31/96 End: 04/30/98 Due: 04/30/99

Shock Trial: Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.

Phase: N/A Priority: Normal
NCT ID: NCT00000552 Org: User:
Start: 09/30/94 End: 12/31/05 Due: 12/31/06

A Multicenter Placebo-Controlled Double-Blind Trial to Evaluate Azidothymidine (AZT) Treatment of the AIDS Dementia Complex and Central Nervous System (CNS) Human Immunodeficiency Virus (HIV) Infection

Phase: N/A Priority: Normal
NCT ID: NCT00000702 Org: User:
Start: - End: 08/31/90 Due: 08/31/91

Studies of the Ocular Complications of AIDS (SOCA)--HPMPC Peripheral CMV Retinitis Trial (HPCRT)

Phase: N/A Priority: Normal
NCT ID: NCT00000142 Org: User:
Start: 04/30/94 End: 02/29/96 Due: 02/28/97

Thrombolysis in Myocardial Ischemia Trial (TIMI III)

Phase: N/A Priority: Normal
NCT ID: NCT00000472 Org: User:
Start: 04/30/89 End: 06/30/95 Due: 06/30/96

Preventing Frequent Sinus Infections in HIV-Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT00000752 Org: User:
Start: - End: 02/28/93 Due: 02/28/94

Alternate-Day Buprenorphine Administration. Phase II - 4

Phase: N/A Priority: Normal
NCT ID: NCT00000222 Org: User:
Start: 07/31/92 End: - Due: -

A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of 100 mcg of Env 2-3 in MF59

Phase: N/A Priority: Normal
NCT ID: NCT00000632 Org: User:
Start: - End: 05/31/92 Due: 05/31/93

A Pharmacologically Guided Phase I/II Study of Daily Orally Administered Synthetic Hypericin in HIV-Infected Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00000792 Org: User:
Start: - End: 01/31/95 Due: 01/31/96

A Multicenter, Double Blind, Comparative Study of Zidovudine Alone Versus Zidovudine and Acyclovir as Treatment for HIV-Infected Patients With CD4+ Counts Less Than 200 Cells/mm3

Phase: N/A Priority: Normal
NCT ID: NCT00000712 Org: User:
Start: - End: 11/30/94 Due: 11/30/95

Congenital Adrenal Hyperplasia: Calcium Channels as Therapeutic Targets

Phase: N/A Priority: Normal
NCT ID: NCT00000102 Org: User:
Start: - End: - Due: -

Coronary Drug Project

Phase: N/A Priority: Normal
NCT ID: NCT00000482 Org: User:
Start: 04/30/65 End: 03/31/85 Due: 03/31/86

Early Manifest Glaucoma Trial (EMGT)

Phase: N/A Priority: Normal
NCT ID: NCT00000132 Org: User:
Start: 10/31/92 End: - Due: -

A Phase I Concentration-Controlled Trial to Assess the Safety, Tolerance, Pharmacokinetics and Development of Decreased HIV-1 Susceptibility to the Combination of Atevirdine Mesylate (U-87201E), Zidovudine (AZT), and Didanosine (ddI)

Phase: N/A Priority: Normal
NCT ID: NCT00000742 Org: User:
Start: - End: 10/31/93 Due: 10/31/94

Extracorporeal Support for Respiratory Insufficiency (ECMO)

Phase: N/A Priority: Normal
NCT ID: NCT00000562 Org: User:
Start: 06/30/74 End: 11/30/79 Due: 11/30/80

Study Comparing Liquid and Tablet Buprenorphine Formulations - 5

Phase: N/A Priority: Normal
NCT ID: NCT00000302 Org: User:
Start: - End: - Due: -

Alterations in Serotonergic Functions in Cocaine Addicts - 1

Phase: N/A Priority: Normal
NCT ID: NCT00000312 Org: User:
Start: - End: - Due: -

Evaluation of the Interaction Between Low Dose Sulfamethoxazole-Trimethoprim and Zidovudine

Phase: N/A Priority: Normal
NCT ID: NCT00000732 Org: User:
Start: - End: 05/31/90 Due: 05/31/91

Buprenorphine Maintenance for Opioid Addicts - 1

Phase: N/A Priority: Normal
NCT ID: NCT00000202 Org: User:
Start: 08/31/88 End: 05/31/06 Due: 05/31/07

Calcium and Bone Mass in Young Females

Phase: N/A Priority: Normal
NCT ID: NCT00000402 Org: User:
Start: 08/31/91 End: 12/31/01 Due: 12/31/02

Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Phase: N/A Priority: Normal
NCT ID: NCT00000542 Org: User:
Start: 08/31/93 End: 03/31/02 Due: 03/31/03

A Phase I, Placebo-Controlled, Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Thalidomide in Subjects With HIV-1 Infection

Phase: N/A Priority: Normal
NCT ID: NCT00000812 Org: User:
Start: - End: 07/31/00 Due: 07/31/01

A Pilot Study of Allogeneic Lymphocyte Transfer in HIV Infection

Phase: N/A Priority: Normal
NCT ID: NCT00000852 Org: User:
Start: - End: - Due: -